Veru Story

<div class='circular--portrait' style='background:#FF6600;color: #FFFAFA;font-size:3em;'>VER</div>
VERU -- USA Stock  

USD 8.90  0.76  7.87%

As many millenniums are trying to avoid healthcare space, it makes sense to review Veru Inc a little further and try to understand its current market patterns. As expected, Veru is starting to reaffirm its true potential as private investors are becoming more and more confident in the future outlook. The returns on the market and returns on Veru appear slightly related to each other for the last few months. Stable basic indicators of the firm may also call for signals of mid-term gains for Veru private investors. Veru Inc is scheduled to announce its earnings today. The next earnings report is expected on the 10th of February 2021. The stock is currently undergoing an active upward rally.
Published over a month ago
View all stories for Veru | View All Stories
Our newest technical analysis of Veru Inc (NASDAQ:VERU)
This firm's average rating is Strong Buy from 4 analysts. Do analysts base this consensus on technical analyses? We know that typical technical analysis utilizes price momentum, patterns, and trends looking at historical prices. It aims to identify signals based on Veru market sentiment investors' perception of the future value of Veru. Let us look at a few aspects of Veru technical analysis. The company has Profit Margin (PM) of (25.78) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (12.47) %, which suggests for every $100 dollars of sales, it generated a net operating loss of -0.12.
Using predictive technical analysis, we will analyze different prices and returns patterns and diagnose historical swings to determine the real value of Veru Inc. In general, we focus on analyzing Veru stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Veru's daily price indicators and compare them against related drivers such as momentum indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Veru's intrinsic value. In addition to deriving basic predictive indicators for Veru, we also check how macroeconomic factors affect Veru price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Veru's stock price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Veru in the context of predictive analytics.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Veru. Your research has to be compared to or analyzed against Veru's peers to derive any actionable benefits. When done correctly, Veru's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Veru Inc.

How does Veru Stands against Peers?

Analyzing Veru competition or peers my help you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Try to analyze the advantages of investing in traded instruments related to Veru across multiple sectors and thematic ideas. A good competitive analysis can cover a lot of different areas. But what areas to choose depends on who you are. The more exhaustive you are in your analysis, the more effective your competitive analysis will be.
Check out Veru Competition Details

How Veru utilizes its cash?

To perform a cash flow analysis of Veru, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Veru is receiving and how much cash it distributes out in a given period. The Veru cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities. Veru Net Cash Flow from Operations is comparatively stable at the moment as compared to the past year. Veru reported Net Cash Flow from Operations of (2.22 Million) in 2020

Closer look at Veru Semi Variance

Veru Inc has current Semi Variance of 3.0. Semi-variance provides a good measure of downside volatility for equity or a portfolio. It is similar to variance, but it only looks at periods where the returns are less than the target or average level.

Semi-variance is the square of semi-deviation. Semi-variance is calculated by averaging the deviations of returns that have a result that is less than the mean.

Semi Variance 
SUM = Summation notation
RET DEV = Actual return deviation over selected period
N(ZERO) = Number of points with returns less than zero
Let's now compare Veru Semi Variance to its closest peers:

Over 3 percent gain for Veru. What does it mean for private investors?

Variance is down to 7.48. It may call for a possible volatility drop. Veru Inc currently demonstrates below-verage downside deviation. It has Information Ratio of 0.1 and Jensen Alpha of 0.32. However, we do advice investors to further question Veru Inc expected returns to ensure all indicators are consistent with the current outlook about its relatively low value at risk.

Our Conclusion on Veru

Whereas some other entities under the biotechnology industry are still a bit expensive, Veru may offer a potential longer-term growth to private investors. On the whole, as of the 9th of December 2020, our analysis shows that Veru slowly supersedes the market. The firm is undervalued and projects very small chance of distress for the next 2 years. Our actual 30 days advice on the firm is Strong Buy.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Vlad Skutelnik do not own shares of Veru Inc. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to